Data search
Results for MligTC455_33551
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_33551 | 1586 | 33.03 | Mlig455_061917 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-1.252 Region-enriched R2: 1.779/0.00392 |
FBN2 | Mlig455_061917 {REF} {Length: 18308} {Pfam: Calcium-binding EGF domain [PF07645.17, score=364.1]; EGF domain [PF12947.9, score=316.0]; Complement Clr-like EGF-like [PF12662.9, score=172.0]; von Willebrand factor type D domain [PF00094.27, score=137.7]; EGF-like domain [PF00008.29, score=67.7]; Human growth factor-like EGF [PF12661.9, score=50.1]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=37.6]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=214, Expect=1e-54]; ENSG00000166147, FBN1, fibrillin 1, [Score=206, Expect=7e-52]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=210, Expect=2e-53]; ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=206, Expect=3e-52]} {Dmel: FBgn0053196, dpy, dumpy, [Score=201, Expect=1e-50]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [Score=202, Expect=3e-51]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=1830, Expect=0.0]} {RNA1509_16188, RNA1509_18848, RNA1509_19247, RNA1509_276} {RNA1310_12, RNA1509_16188, RNA1509_18848, RNA1509_19247, RNA1509_276} {RNA1509_16188, RNA1509_18848, RNA1509_19247, RNA1509_276, RNA815_32} |
Cumulative graph for MligTC455_33551
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -0.463 | 5.227 | 0.63287 | 1.00000 | |
| RegionR2 | 1.779 | 5.227 | 0.00010 | 0.00392 | |
| RegionR3 | 0.556 | 5.227 | 0.14532 | 0.64902 | |
| RegionR4 | -0.194 | 5.227 | 0.68366 | 0.97663 | |
| RegionR5 | -0.852 | 5.227 | 0.03248 | 0.13742 | |
| RegionR6 | -0.582 | 5.227 | 0.17440 | 0.73343 | |
| RegionR7 | 0.019 | 5.227 | 0.96888 | 1.00000 | |
| RegionR8 | -0.263 | 5.227 | 0.68962 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | 1.342 | 5.227 | 0.22449 | 0.95604 | |
| RegenerationR2 | -0.305 | 5.227 | 0.47909 | 0.86294 | |
| RegenerationR3 | 0.66 | 5.227 | 0.15488 | 0.58544 | |
| RegenerationR4 | 0.342 | 5.227 | 0.49441 | 0.86699 | |
| RegenerationR5 | 0.699 | 5.227 | 0.13699 | 0.54743 | |
| RegenerationR6 | 1.005 | 5.227 | 0.03721 | 0.24061 | |
| RegenerationBL | 0.031 | 5.227 | 0.95058 | 1.00000 | |
| RegenerationTP | -0.398 | 5.227 | 0.51022 | 0.90719 |
Genes with expression patterns similar to MligTC455_33551
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_33551 | 1586 | 33.03 | Mlig455_061917 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-1.252 Region-enriched R2: 1.779/0.00392 |
FBN2 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_061917 {REF} {Length: 18308} {Pfam: Calcium-binding EGF domain [PF07645.17, score=364.1]; EGF domain [PF12947.9, score=316.0]; Complement Clr-like EGF-like [PF12662.9, score=172.0]; von Willebrand factor type D domain [PF00094.27, score=137.7]; EGF-like domain [PF00008.29, score=67.7]; Human growth factor-like EGF [PF12661.9, score=50.1]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=37.6]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=214, Expect=1e-54]; ENSG00000166147, FBN1, fibrillin 1, [Score=206, Expect=7e-52]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=210, Expect=2e-53]; ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=206, Expect=3e-52]} {Dmel: FBgn0053196, dpy, dumpy, [Score=201, Expect=1e-50]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [Score=202, Expect=3e-51]} {Smed: dd_Smed_v6_2649_0_2, dd_Smed_v6_2649_0_2, [Score=1830, Expect=0.0]} {RNA1509_16188, RNA1509_18848, RNA1509_19247, RNA1509_276} {RNA1310_12, RNA1509_16188, RNA1509_18848, RNA1509_19247, RNA1509_276} {RNA1509_16188, RNA1509_18848, RNA1509_19247, RNA1509_276, RNA815_32} |
| 2. | MligTC455_38698 | 945 | 19.68 | Mlig455_009780 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.658 Region-enriched R2: 1.739/0.00137 Regeneration-downregulated BL: -2.534 Regeneration-depleted BL: -2.534 |
COLEC10 | 2.684 | - | 0.831 | - | 0.959 | 0.894 | - | Mlig455_009780 {REF} {Length: 1506} {Pfam: Lectin C-type domain [PF00059.23, score=43.5]} {Human: ENSG00000184374, COLEC10, collectin subfamily member 10, [Score=50.4, Expect=2e-07]} {Mouse: ENSMUSG00000038591, Colec10, collectin sub-family member 10, [Score=47.8, Expect=1e-06]} {RNA1509_22697} {RNA1310_23822} {RNA815_11460} |
| 3. | MligTC455_33550 | 2612 | 54.42 | Mlig455_009474 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-1.072 Region-enriched R2: 2.002/0.00035 |
FBN2 | 1.894 | - | 0.943 | - | - | 0.951 | - | Mlig455_009474 {REF} {Length: 17362} {Pfam: Calcium-binding EGF domain [PF07645.17, score=979.2]; EGF domain [PF12947.9, score=843.5]; Complement Clr-like EGF-like [PF12662.9, score=499.6]; EGF-like domain [PF00008.29, score=186.8]; von Willebrand factor type D domain [PF00094.27, score=136.1]; Human growth factor-like EGF [PF12661.9, score=131.2]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=37.5]; MSP1 EGF domain 1 [PF12946.9, score=22.6]; Pvs28 EGF domain [PF06247.13, score=20.7]; Coagulation Factor Xa inhibitory site [PF14670.8, score=20.0]} {Human: ENSG00000138829, FBN2, fibrillin 2, [RH, Score=597, Expect=5e-171]; ENSG00000166147, FBN1, fibrillin 1, [RH, Score=586, Expect=2e-167]; ENSG00000142449, FBN3, fibrillin 3, [RH, Score=575, Expect=4e-164]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [RH, Score=595, Expect=2e-170]} {Dmel: FBgn0053196, dpy, dumpy, [RH, Score=367, Expect=2e-100]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [Score=246, Expect=3e-64]} {Smed: dd_Smed_v6_2649_0_1, dd_Smed_v6_2649_0_1, [RH, Score=2446, Expect=0.0]} {RNA1509_276} {RNA1310_12} {RNA815_32} |
| 4. | MligTC455_33549 | 2604 | 54.26 | Mlig455_009464 | Neo: - Age: - Region-enriched R2: 2.001/0.00039 |
FBN2 | 1.893 | - | 0.943 | - | - | 0.950 | - | Mlig455_009464 {REF} {Length: 1474} {Pfam: Calcium-binding EGF domain [PF07645.17, score=979.2]; EGF domain [PF12947.9, score=843.5]; Complement Clr-like EGF-like [PF12662.9, score=499.6]; EGF-like domain [PF00008.29, score=186.8]; von Willebrand factor type D domain [PF00094.27, score=136.1]; Human growth factor-like EGF [PF12661.9, score=131.2]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=37.5]; MSP1 EGF domain 1 [PF12946.9, score=22.6]; Pvs28 EGF domain [PF06247.13, score=20.7]; Coagulation Factor Xa inhibitory site [PF14670.8, score=20.0]} {Human: ENSG00000138829, FBN2, fibrillin 2, [RH, Score=597, Expect=5e-171]; ENSG00000166147, FBN1, fibrillin 1, [RH, Score=586, Expect=2e-167]; ENSG00000142449, FBN3, fibrillin 3, [RH, Score=575, Expect=4e-164]} {Mouse: ENSMUSG00000024598, Fbn2, fibrillin 2, [RH, Score=595, Expect=2e-170]} {Dmel: FBgn0053196, dpy, dumpy, [RH, Score=367, Expect=2e-100]} {Celegans: WBGene00022816, fbn-1, FBN-1A.1; FiBrilliN homolog, [Score=246, Expect=3e-64]} {Smed: dd_Smed_v6_2649_0_1, dd_Smed_v6_2649_0_1, [RH, Score=2446, Expect=0.0]} {RNA1509_276} {RNA1310_12} {RNA815_32} |
| 5. | MligTC455_19449 | 235 | 4.9 | Mlig455_048896 | Neo: - Age: logFC(26M/2M)=-0.470 Region-enriched R2: 3.185/0.00006 |
1.718 | - | - | - | 0.956 | 0.762 | - | Mlig455_048896 {REF} {Length: 1819} {Pfam: Innexin [PF00876.20, score=25.6]} {RNA1509_47060} {RNA1310_19756.1, RNA1509_47060} {RNA1509_47060, RNA815_16217} | |
| 6. | MligTC455_39210 | 56 | 1.16 | Mlig455_061908 | Neo: - Age: - |
0.963 | - | - | - | 0.963 | - | - | Mlig455_061908 {REF} {Length: 2036} {RNA1509_51310} {RNA1310_26948} {RNA815_26428} | |
| 7. | MligTC455_12089 | 43 | 0.89 | Mlig455_005558 | Neo: - Age: - |
0.959 | - | - | - | 0.959 | - | - | Mlig455_005558 {REF} {Length: 1871} {RNA1509_50426} {RNA1310_116483} {RNA815_44149} | |
| 8. | MligTC455_45719 | 94 | 1.96 | Mlig455_056535 | Neo: - Age: - |
CHRNA6 | 0.956 | - | - | - | 0.956 | - | - | Mlig455_056535 {REF} {Length: 2532} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=102.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=75.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=127, Expect=1e-31]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=125, Expect=4e-31]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=125, Expect=5e-31]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=120, Expect=1e-29]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=117, Expect=4e-28]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=125, Expect=3e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=122, Expect=4e-30]} {RNA1509_7752} {RNA1310_37530} {RNA815_18433} |
Berezikov Lab - 2020-2021 © ERIBA